In Situ Proliferating Peptide Nanoparticle Augments Multi‐Target Intervention of Secondary Brain Damage Following Subarachnoid Hemorrhage
Abstract Subarachnoid hemorrhage (SAH), a lethal stroke subtype, involves complex pathological cascades triggered by neuro‐glial units for persistent neuroinflammation, oxidative damage and programmed neuronal cell death. Single‐target and traditional multi‐target therapies, derived from individual...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-08-01
|
| Series: | Advanced Science |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/advs.202417456 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849227282453889024 |
|---|---|
| author | Yibin Zhang Peisen Yao Fuxiang Chen Shufa Zheng Xuegang Niu Haojie Wang Yuanxiang Lin Bin Gao Dezhi Kang |
| author_facet | Yibin Zhang Peisen Yao Fuxiang Chen Shufa Zheng Xuegang Niu Haojie Wang Yuanxiang Lin Bin Gao Dezhi Kang |
| author_sort | Yibin Zhang |
| collection | DOAJ |
| description | Abstract Subarachnoid hemorrhage (SAH), a lethal stroke subtype, involves complex pathological cascades triggered by neuro‐glial units for persistent neuroinflammation, oxidative damage and programmed neuronal cell death. Single‐target and traditional multi‐target therapies, derived from individual drugs, show limited efficacy in addressing these interconnected events, due to spatiotemporal heterogeneity of action in single‐target components. This highlights the urgent need for not only new therapeutic targets, but advanced multi‐target drugs. Herein, we identify elevated cell‐free DNA (cfDNA), a key neuroinflammatory driver, as correlated with SAH severity and poor prognosis, suggesting its therapeutic potential. Furthermore, a novel “in situ proliferation” strategy is proposed and a flexible multi‐target peptide nanoparticle is developed through co‐assembling matrix metalloproteinase‐2 responsive cationic peptide and glutathione peroxidase‐mimicking peptide (GPXP). Upon reaching injury lesions, this system splits into two individual drugs: cationic peptide scavenges pathological cfDNA and inhibits microglia‐mediated neuroinflammation, while GPXP protects neurons against oxidative damage and neuronal apoptosis/ferroptosis. Consequently, this strategy proves superior therapeutic effects on reducing secondary brain injury and promoting neurofunctional recovery in SAH mice. These findings not only highlight the essential role of cfDNA in SAH but offer a flexible resolution to advance multi‐target combinational therapy. |
| format | Article |
| id | doaj-art-3d6acb51f4204d78bfd4a65429dfaad4 |
| institution | Kabale University |
| issn | 2198-3844 |
| language | English |
| publishDate | 2025-08-01 |
| publisher | Wiley |
| record_format | Article |
| series | Advanced Science |
| spelling | doaj-art-3d6acb51f4204d78bfd4a65429dfaad42025-08-23T14:14:55ZengWileyAdvanced Science2198-38442025-08-011231n/an/a10.1002/advs.202417456In Situ Proliferating Peptide Nanoparticle Augments Multi‐Target Intervention of Secondary Brain Damage Following Subarachnoid HemorrhageYibin Zhang0Peisen Yao1Fuxiang Chen2Shufa Zheng3Xuegang Niu4Haojie Wang5Yuanxiang Lin6Bin Gao7Dezhi Kang8Department of Neurosurgery Neurosurgery Research Institute The First Affiliated Hospital Fujian Medical University Fuzhou Fujian 350005 ChinaDepartment of Neurosurgery Neurosurgery Research Institute The First Affiliated Hospital Fujian Medical University Fuzhou Fujian 350005 ChinaDepartment of Neurosurgery Neurosurgery Research Institute The First Affiliated Hospital Fujian Medical University Fuzhou Fujian 350005 ChinaDepartment of Neurosurgery Neurosurgery Research Institute The First Affiliated Hospital Fujian Medical University Fuzhou Fujian 350005 ChinaDepartment of Neurosurgery Neurosurgery Research Institute The First Affiliated Hospital Fujian Medical University Fuzhou Fujian 350005 ChinaDepartment of Neurosurgery Neurosurgery Research Institute The First Affiliated Hospital Fujian Medical University Fuzhou Fujian 350005 ChinaDepartment of Neurosurgery Neurosurgery Research Institute The First Affiliated Hospital Fujian Medical University Fuzhou Fujian 350005 ChinaDepartment of Neurosurgery Neurosurgery Research Institute The First Affiliated Hospital Fujian Medical University Fuzhou Fujian 350005 ChinaDepartment of Neurosurgery Neurosurgery Research Institute The First Affiliated Hospital Fujian Medical University Fuzhou Fujian 350005 ChinaAbstract Subarachnoid hemorrhage (SAH), a lethal stroke subtype, involves complex pathological cascades triggered by neuro‐glial units for persistent neuroinflammation, oxidative damage and programmed neuronal cell death. Single‐target and traditional multi‐target therapies, derived from individual drugs, show limited efficacy in addressing these interconnected events, due to spatiotemporal heterogeneity of action in single‐target components. This highlights the urgent need for not only new therapeutic targets, but advanced multi‐target drugs. Herein, we identify elevated cell‐free DNA (cfDNA), a key neuroinflammatory driver, as correlated with SAH severity and poor prognosis, suggesting its therapeutic potential. Furthermore, a novel “in situ proliferation” strategy is proposed and a flexible multi‐target peptide nanoparticle is developed through co‐assembling matrix metalloproteinase‐2 responsive cationic peptide and glutathione peroxidase‐mimicking peptide (GPXP). Upon reaching injury lesions, this system splits into two individual drugs: cationic peptide scavenges pathological cfDNA and inhibits microglia‐mediated neuroinflammation, while GPXP protects neurons against oxidative damage and neuronal apoptosis/ferroptosis. Consequently, this strategy proves superior therapeutic effects on reducing secondary brain injury and promoting neurofunctional recovery in SAH mice. These findings not only highlight the essential role of cfDNA in SAH but offer a flexible resolution to advance multi‐target combinational therapy.https://doi.org/10.1002/advs.202417456MMP‐2 responsivenessmulti‐target of combinationpeptide nanoparticlesecondary brain injurysubarachnoid hemorrhage |
| spellingShingle | Yibin Zhang Peisen Yao Fuxiang Chen Shufa Zheng Xuegang Niu Haojie Wang Yuanxiang Lin Bin Gao Dezhi Kang In Situ Proliferating Peptide Nanoparticle Augments Multi‐Target Intervention of Secondary Brain Damage Following Subarachnoid Hemorrhage Advanced Science MMP‐2 responsiveness multi‐target of combination peptide nanoparticle secondary brain injury subarachnoid hemorrhage |
| title | In Situ Proliferating Peptide Nanoparticle Augments Multi‐Target Intervention of Secondary Brain Damage Following Subarachnoid Hemorrhage |
| title_full | In Situ Proliferating Peptide Nanoparticle Augments Multi‐Target Intervention of Secondary Brain Damage Following Subarachnoid Hemorrhage |
| title_fullStr | In Situ Proliferating Peptide Nanoparticle Augments Multi‐Target Intervention of Secondary Brain Damage Following Subarachnoid Hemorrhage |
| title_full_unstemmed | In Situ Proliferating Peptide Nanoparticle Augments Multi‐Target Intervention of Secondary Brain Damage Following Subarachnoid Hemorrhage |
| title_short | In Situ Proliferating Peptide Nanoparticle Augments Multi‐Target Intervention of Secondary Brain Damage Following Subarachnoid Hemorrhage |
| title_sort | in situ proliferating peptide nanoparticle augments multi target intervention of secondary brain damage following subarachnoid hemorrhage |
| topic | MMP‐2 responsiveness multi‐target of combination peptide nanoparticle secondary brain injury subarachnoid hemorrhage |
| url | https://doi.org/10.1002/advs.202417456 |
| work_keys_str_mv | AT yibinzhang insituproliferatingpeptidenanoparticleaugmentsmultitargetinterventionofsecondarybraindamagefollowingsubarachnoidhemorrhage AT peisenyao insituproliferatingpeptidenanoparticleaugmentsmultitargetinterventionofsecondarybraindamagefollowingsubarachnoidhemorrhage AT fuxiangchen insituproliferatingpeptidenanoparticleaugmentsmultitargetinterventionofsecondarybraindamagefollowingsubarachnoidhemorrhage AT shufazheng insituproliferatingpeptidenanoparticleaugmentsmultitargetinterventionofsecondarybraindamagefollowingsubarachnoidhemorrhage AT xuegangniu insituproliferatingpeptidenanoparticleaugmentsmultitargetinterventionofsecondarybraindamagefollowingsubarachnoidhemorrhage AT haojiewang insituproliferatingpeptidenanoparticleaugmentsmultitargetinterventionofsecondarybraindamagefollowingsubarachnoidhemorrhage AT yuanxianglin insituproliferatingpeptidenanoparticleaugmentsmultitargetinterventionofsecondarybraindamagefollowingsubarachnoidhemorrhage AT bingao insituproliferatingpeptidenanoparticleaugmentsmultitargetinterventionofsecondarybraindamagefollowingsubarachnoidhemorrhage AT dezhikang insituproliferatingpeptidenanoparticleaugmentsmultitargetinterventionofsecondarybraindamagefollowingsubarachnoidhemorrhage |